Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 10, 2025
- Accession no.
- 0001673232-25-000003
- Filed
- Sep 10, 2025
- Trade date
- Sep 8-9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 16 non-derivative transactions and 4 derivative transactions. Open-market sales total $6.48M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Common Stock | MOption exerciseAcquired | +3,250 | $135.42 | +$440,115 | 3,250 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −417 | $389.81 | −$162,550.77 | 2,833 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −1,000 | $391.16 | −$391,160 | 1,833 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −1,100 | $392.18 | −$431,398 | 733 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −300 | $394.08 | −$118,224 | 433 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −233 | $395.03 | −$92,041.99 | 200 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −200 | $396.23 | −$79,246 | 0 | Indirect | |
| Sep 8, 2025 | Common Stock | MOption exerciseAcquired | +1,750 | $146.03 | +$255,552.5 | 1,750 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −500 | $390.46 | −$195,230 | 1,250 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −400 | $391.42 | −$156,568 | 850 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −400 | $392.51 | −$157,004 | 450 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −350 | $394.33 | −$138,015.5 | 100 | Indirect | |
| Sep 8, 2025 | Common Stock | SSaleDisposed | −100 | $396.10 | −$39,610 | 0 | Indirect | |
| Sep 9, 2025 | Common Stock | MOption exerciseAcquired | +11,375 | $397.41 | +$4,520,538.75 | 11,375 | Indirect | |
| Sep 9, 2025 | Common Stock | SSaleDisposed | −4,875 | $393.86 | −$1,920,067.5 | 6,500 | Indirect | |
| Sep 9, 2025 | Common Stock | SSaleDisposed | −6,500 | $400.08 | −$2,600,520 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Common Stock | MOption exerciseDisposed | −3,250 | $0.00 | $0 | 169,625 | Indirect | |
| Sep 8, 2025 | Common Stock | MOption exerciseDisposed | −1,750 | $0.00 | $0 | 24,500 | Indirect | |
| Sep 9, 2025 | Common Stock | MOption exerciseDisposed | −11,375 | $0.00 | $0 | 158,250 | Indirect | |
| Sep 9, 2025 | Common Stock | MOption exerciseDisposed | −6,125 | $0.00 | $0 | 49,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.